Untilthis moment, QCM-D and SPR studies on lung cancer cell-derived EVsfocused mainly on CD63 detection.29−31 The proposed protocolwas validated for its specificity, limit of detection (LOD), and limitof quantification (LOQ). Here, CD63 is linked to lung carcinoma.